HN1999000171A - Concentrado oral de sertralina. - Google Patents

Concentrado oral de sertralina.

Info

Publication number
HN1999000171A
HN1999000171A HN1999000171A HN1999000171A HN1999000171A HN 1999000171 A HN1999000171 A HN 1999000171A HN 1999000171 A HN1999000171 A HN 1999000171A HN 1999000171 A HN1999000171 A HN 1999000171A HN 1999000171 A HN1999000171 A HN 1999000171A
Authority
HN
Honduras
Prior art keywords
sertralina
oral concentrate
concentrate
oral
present
Prior art date
Application number
HN1999000171A
Other languages
English (en)
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Priority to HN1999000171A priority Critical patent/HN1999000171A/es
Publication of HN1999000171A publication Critical patent/HN1999000171A/es

Links

Landscapes

  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

LA PRESENTE INVENCION SE REFIERE A UN CONCENTRADO ORAL DE SERTRALINA.
HN1999000171A 1999-10-04 1999-10-04 Concentrado oral de sertralina. HN1999000171A (es)

Priority Applications (1)

Application Number Priority Date Filing Date Title
HN1999000171A HN1999000171A (es) 1999-10-04 1999-10-04 Concentrado oral de sertralina.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HN1999000171A HN1999000171A (es) 1999-10-04 1999-10-04 Concentrado oral de sertralina.

Publications (1)

Publication Number Publication Date
HN1999000171A true HN1999000171A (es) 2000-01-12

Family

ID=53835783

Family Applications (1)

Application Number Title Priority Date Filing Date
HN1999000171A HN1999000171A (es) 1999-10-04 1999-10-04 Concentrado oral de sertralina.

Country Status (1)

Country Link
HN (1) HN1999000171A (es)

Similar Documents

Publication Publication Date Title
HN1999000066A (es) Formulaciones farmaceuticas
HN1998000057A (es) Derivados de nicotinamida
HN1999000089A (es) Formulaciones de ziprasidona
HN1999000125A (es) Nuevos derivados sustituidos del pirazol
HN1998000132A (es) Combinaciones terapeuticas
HN1999000155A (es) 4-carboxiamino-2-metil-1,2,3,4-tetrahidroquinolinas
HN1998000011A (es) Derivados de acidos arilsulfonilaminohidroxamicos
HN1998000086A (es) Derivados de 9 - desofo - 9 aza - 9a - homoeritromicina a - c - 4 sustituidos.
HN1998000036A (es) Compuesto de pirazina
HN1997000126A (es) Derivados de indazol
HN1997000023A (es) Derivados de lactama
HN1998000124A (es) Terapia de combinacion
HN1998000030A (es) 2-amino-6-(4fenoxi-2-sustituido)-piridinas sustituidas
HN1998003689A (es) Azetidinas
HN1998000106A (es) Composiciones parenterales de alatroflaxacino
HN1998000199A (es) Agentes terapeuticos
HN1998000193A (es) Compuestos de triazina
HN1998000102A (es) Composiciones solubilizadas de sertralina
HN1999000171A (es) Concentrado oral de sertralina.
HN1999000202A (es) Derivados de higromicina
HN1998000024U (es) Anillo promocional
HN1999000181A (es) Formulaciones antiparasitarias.
HN2000000205A (es) Derivados de purina
HN2000000276A (es) Derivados de tiazolilamida
HN2001000135A (es) Derivados de purina